Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
ExSight Ventures is an early-stage venture capital firm founded to address the funding shortage for life science companies, particularly in ophthalmology. Established in the United States, the firm focuses on innovative diagnostic and treatment solutions for eye care. The firm recognizes the critical need for capital in the ophthalmic sector, which has historically faced challenges in securing early-stage investments.
Currently, ExSight Ventures manages a portfolio of nine companies, all dedicated to advancing technologies in the ophthalmic field. The firm emphasizes capital-efficient investments that drive significant value creation. Their team comprises experienced professionals with backgrounds in law and medicine, enhancing their ability to evaluate and support emerging technologies in this specialized sector.
ExSight Ventures targets early-stage companies in biotechnology, medical devices, pharmaceuticals, and software solutions related to ophthalmology. The firm invests in funding rounds from pre-seed to Series B, emphasizing capital-efficient opportunities that can lead to substantial value creation. Their investment strategy is rooted in a deep understanding of the ophthalmic sector, allowing them to identify and support breakthrough technologies aimed at diagnosing and treating vision diseases.
The firm’s investment thesis highlights the importance of domain expertise in ophthalmology, which guides their decision-making process. ExSight Ventures seeks to partner with founders who demonstrate a strong commitment to innovation and possess the technical knowledge necessary to advance their projects in the competitive landscape of eye care.
ExSight Ventures has invested in nine transformative ophthalmic companies, focusing on innovative solutions that address various aspects of eye care. While specific names and descriptions of these portfolio companies are not disclosed, the firm’s commitment to the ophthalmic sector is evident through its targeted investments in biotechnology, medical devices, and pharmaceuticals.
The firm’s portfolio reflects a diverse range of technologies aimed at improving vision health, showcasing ExSight Ventures' dedication to supporting early-stage companies that are poised to make significant impacts in the field of ophthalmology.
James C. Murray, J.D., Partner - James has a background in law and brings extensive experience in venture capital and corporate governance. His expertise includes guiding startups through legal complexities and funding processes.
Dr. Michael Nissen, Partner - Dr. Nissen has a strong background in medicine and healthcare innovation. He focuses on identifying promising technologies in the ophthalmic sector and supporting their development.
Dr. Firas M. Rahhal, Partner - Dr. Rahhal specializes in ophthalmology and has a deep understanding of the medical device landscape. His insights are invaluable for evaluating potential investments in this field.
To pitch ExSight Ventures, founders should visit their website at ExSight Ventures. It is advisable to include a clear overview of the business model, market opportunity, and technology in the pitch deck. Specific application forms or portals are not mentioned, and response time expectations are not disclosed.
What are ExSight Ventures' investment criteria?
ExSight Ventures focuses on early-stage companies in the ophthalmic sector, specifically in biotechnology, medical devices, pharmaceuticals, and software solutions. They invest in funding rounds from pre-seed to Series B, emphasizing capital-efficient opportunities.
How can I apply or pitch to ExSight Ventures?
Founders interested in pitching to ExSight Ventures can visit their website at ExSight Ventures for more information on the application process. Specific email addresses for pitches are not provided.
What makes ExSight Ventures different from other venture capital firms?
ExSight Ventures specializes exclusively in the ophthalmic sector, addressing a significant gap in early-stage funding for life science companies. Their focus on domain expertise allows them to identify and support breakthrough technologies in eye care.
What is the geographic scope of ExSight Ventures' investments?
The firm primarily invests in companies based in the United States, focusing on innovative solutions within the ophthalmic sector.
What is ExSight Ventures' approach to post-investment involvement?
While specific details about post-investment involvement are not disclosed, ExSight Ventures emphasizes the importance of supporting their portfolio companies through their expertise in law and medicine.
What is the typical check size for investments made by ExSight Ventures?
ExSight Ventures invests in capital-efficient opportunities, but specific check size ranges are not provided. Their focus is on early-stage funding rounds, which typically involve smaller investments compared to later stages.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.